Akoya Biosciences, Inc. (AKYA) 13D/13G Filings for Quanterix Corporation (QTRX)

Akoya Biosciences, Inc. 13D and 13G filings for Quanterix Corporation:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-01-16
9:29 pm
Purchase
2025-01-0913DQuanterix Corporation
QTRX
Akoya Biosciences Inc.
AKYA
2,955,532
6.200%
2,955,532increase
(New Position)
Filing